Impact of bronchodilator therapy on diaphragmatic function in sleep in COPD
N. Domnik (Kingston (ON), Canada), R. Scheeren (Kingston (ON), Canada), S. Taylor (Kingston (ON), Canada), H. Driver (Kingston (ON), Canada), S. Crinion (Kingston (ON), Canada), J. Neder (Kingston (ON), Canada), D. O'Donnell (Kingston (ON), Canada)
Source: Virtual Congress 2020 – Exploring respiratory function
Session: Exploring respiratory function
Session type: Oral Presentation
Number: 4404
Disease area: Airway diseases, Sleep and breathing disorders
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Domnik (Kingston (ON), Canada), R. Scheeren (Kingston (ON), Canada), S. Taylor (Kingston (ON), Canada), H. Driver (Kingston (ON), Canada), S. Crinion (Kingston (ON), Canada), J. Neder (Kingston (ON), Canada), D. O'Donnell (Kingston (ON), Canada). Impact of bronchodilator therapy on diaphragmatic function in sleep in COPD. 4404
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Effect of inhaled bronchodilator therapy on the bacterioexcretion and on the quality of life (LQ) of pulmonary TB patients with concomitant lung obstructive syndrome Source: Eur Respir J 2006; 28: Suppl. 50, 8s Year: 2006
Effects of long-acting bronchodilators on changes of inspiratory capacity by hyperventilation in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 430s Year: 2006
Nebulized bronchodilator therapy in stable COPD – effect on quality of life and spirometry Source: Eur Respir J 2006; 28: Suppl. 50, 64s Year: 2006
Effect of nasal CPAP therapy on functional respiratory parameters and cardiopulmonary exercise test in obstructive sleep apnea syndrome Source: Annual Congress 2012 - Physiology, obesity and the downstream effects of OSA Year: 2012
Effect of nasal topical steroids on CPAP compliance in patients with obstructive sleep apnoea starting therapy Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea Year: 2007
Efficacy of long-acting bronchodilator inhalation on postoperative pulmonary function and quality of life in lung cancer patients with chronic obstructive pulmonary disease Source: Annual Congress 2008 - Actual challenges in thoracic surgery Year: 2008
Functional effectiveness of auto-CPAP therapy in COPD patients with obstructive sleep apnea Source: International Congress 2016 – Noninvasive ventilation and beyond: novelties and real-life applications Year: 2016
Particularities of clinical-functional characteristics of combination pathology - obstructive sleep apnea-hypopnea syndrome and bronchial asthma during the treatment with prolonged beta2-agonists Source: Eur Respir J 2003; 22: Suppl. 45, 468s Year: 2003
Clinical implications of residual sleep apnoea after chronic CPAP therapy Source: Breathe 2011; 7: 289-290 Year: 2011
Improvement in airflow obstruction with inhaled bronchodilators influences the pattern of abdominal muscle recruitment during exercise in COPD Source: Annual Congress 2010 - Thoracic dynamics and dyspnoea on exercise Year: 2010
PAP therapy impact on COPD exacerbations rate in patients with overlap syndrome Source: International Congress 2015 – To treat or not to treat, and how? Sleep-disordered breathing I Year: 2015
Factors influencing efficacy of BiPAP therapy in severe obstructive sleep apnea Source: Annual Congress 2013 –Sleep disordered breathing in special situations III Year: 2013
Dose-dependent effects of bronchodilator therapy on the clinical outcomes of exacerbation of COPD requiring non-invasive ventilation (NIV) Source: Eur Respir J 2003; 22: Suppl. 45, 403s Year: 2003
Influence of combined antiasthmatic basic therapy on hyperinflation in patients with severe bronchial asthma Source: Eur Respir J 2007; 30: Suppl. 51, 553s Year: 2007
Changes in the quality of life of pulmonary TB patients depending on the severity of bronchial obstruction when using standard antituberculosis therapy and inhaled bronchodilator therapy Source: Eur Respir J 2003; 22: Suppl. 45, 21s Year: 2003
Antioxidant status in obstructive sleep apnea: no influence of one night continuous airway pressure therapy Source: Eur Respir J 2006; 28: Suppl. 50, 574s Year: 2006
Impact of CPAP on asthmatic patients with obstructive sleep apnoea Source: Eur Respir J 2007; 29: 307-311 Year: 2007
Effect of auto-CPAP therapy on parameters of rhinomanometry in patients with COPD combined with OSAHS Source: International Congress 2016 – Features and impact of comorbidities in COPD Year: 2016
Effects of supplemental oxygen and high-dose inhaled bronchodilator therapy in exercise performance and dyspnoea in patients with stable COPD Source: Annual Congress 2004 - Exercise and systemic effects in COPD Year: 2004
Effect of five-years treatment with nCPAP on left ventricle function in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2001; 18: Suppl. 33, 418s Year: 2001